Share Twitter LinkedIn Facebook Email Brian M. Shuch, MD Yale School of Medicine, discusses how S1500’s Completion May Alter Standard of Care for PRCC Compares 3 pool MET inhibitors to Sutent as a comparator arm at Kidney Cancer Association 2017 in Miami.
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD Acute Lymphoblastic Leukemia 4 Mins Read
FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia Acute Lymphoblastic Leukemia 3 Mins Read